• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dow Gains Over 50 Points; Neogen Posts Downbeat Earnings

    4/9/24 9:51:06 AM ET
    $ACRV
    $HUBC
    $LASE
    $MDIA
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Computer Communications Equipment
    Telecommunications
    Get the next $ACRV alert in real time by email

    U.S. stocks traded higher this morning, with the Dow Jones index gaining over 50 points on Tuesday.

    Following the market opening Tuesday, the Dow traded up 0.20% to 38,972.32 while the NASDAQ rose 0.40% to 16,319.23. The S&P 500 also rose, gaining, 0.32% to 5,219.29.

    Check This Out: Robinhood To Rally Around 51%? Here Are 10 Top Analyst Forecasts For Tuesday

     

    Leading and Lagging Sectors

     

    Communication services shares jumped by 0.8% on Tuesday.

    In trading on Tuesday, financial shares rose by just 0.1%.

     

    Top Headline

     

    Neogen Corporation (NASDAQ:NEOG) reported worse than expected third-quarter earnings and cut 2024 guidance.

    Neogen posted adjusted earnings of 12 cents per share, missing market expectations of 14 cents per share. The company’s quarterly sales came in at $228.812 million versus estimates of $230.011 million.

     

    Equities Trading UP

     

    Laser Photonics Corporation (NASDAQ:LASE) shares shot up 174% to $3.9250 after the company announced it secured an order for its LaserTower COMPACT marking and engraving system from L3Harris Technologies.

    Shares of Acrivon Therapeutics, Inc. (NASDAQ:ACRV) got a boost, surging 54% to $9.11. The company announced a $130 million private placement financing.

    MediaCo Holding Inc. (NASDAQ:MDIA) shares were also up, gaining 40% to $4.22.

     

    Equities Trading DOWN

     

    Vincerx Pharma, Inc. (NASDAQ:VINC) shares dropped 68% to $1.5092 after the company presented preliminary Phase 1 data for VIP236 and updates on pipeline progress at the AACR Annual Meeting 2024.

    Shares of Eco Wave Power Global AB (NASDAQ:WAVE) were down 30% to $2.96. Eco Wave Power Global shares jumped 219% on Monday after the company announced that it was selected by an

    HUB Cyber Security Ltd. (NASDAQ:HUBC) was down, falling 18% to $1.10.

    Also Check This Out: Bitcoin Falls Below $71,000 Data; Wormhole, Core Among Top Losers

     

    Commodities

     

    In commodity news, oil traded down 0.1% to $86.35 while gold traded up 0.9% at $2,371.40.

    Silver traded up 1.1% to $28.125 on Tuesday, while copper rose 0.6% to $4.30.

     

    Euro zone

     

    European shares were mostly lower today. The eurozone’s STOXX 600 fell 0.2%, London’s FTSE 100 rose 0.1% while Spain’s IBEX 35 Index fell 0.2% The German DAX fell 0.7% French CAC 40 fell 0.5% while Italy’s FTSE MIB Index fell 0.5%.

    French trade deficit shrank to €5.2 billion in February 2024 versus a revised €7.2 billion gap in the prior month. Retail sales in the UK gained 3.2% from a year ago in March.

     

    Asia Pacific Markets

     

    Asian markets closed mostly higher on Tuesday, with Japan’s Nikkei 225 gaining 1.08%, Hong Kong’s Hang Seng Index gaining 0.57%, China’s Shanghai Composite gaining 0.05% and India’s S&P BSE Sensex falling 0.08%.

    Foreign exchange reserves in Hong Kong fell to $423.6 billion in March from $425.2 billion in the prior month. Japanese machine tool orders fell 8.5% year-over-year to JPY 135,647 million in March compared to a 8% decline in the prior month, while consumer confidence index in Japan rose to 39.5 in March versus a revised reading of 39.0 in the prior month.

     

    Economics

     

    The NFIB Small Business Optimism Index declined for a third straight month to a reading of 88.5 in March, compared to market estimates of 90.2.

    Now Read This: Jim Cramer Was Upset At This Hostile Takeover, But 'They Fixed The Situation. Stock's Been A Horse'

    Get the next $ACRV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACRV
    $HUBC
    $LASE
    $MDIA

    CompanyDatePrice TargetRatingAnalyst
    Neogen Corporation
    $NEOG
    7/29/2025Outperform → Mkt Perform
    William Blair
    Acrivon Therapeutics Inc.
    $ACRV
    5/5/2025$6.00Overweight
    Piper Sandler
    Eco Wave Power Global AB
    $WAVE
    3/11/2025$15.00Buy
    Maxim Group
    Eco Wave Power Global AB
    $WAVE
    2/3/2025$14.00Buy
    Alliance Global Partners
    Acrivon Therapeutics Inc.
    $ACRV
    1/31/2025Overweight
    KeyBanc Capital Markets
    Neogen Corporation
    $NEOG
    12/19/2024$15.00Buy
    Guggenheim
    Acrivon Therapeutics Inc.
    $ACRV
    9/16/2024$16.00Neutral → Buy
    Ladenburg Thalmann
    Acrivon Therapeutics Inc.
    $ACRV
    4/29/2024Buy → Neutral
    Ladenburg Thalmann
    More analyst ratings

    $ACRV
    $HUBC
    $LASE
    $MDIA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    HUB Cyber Security Ltd. Launches SecureRide™ Trust Infrastructure for the $400B+ Global Rideshare Market

    LOS ANGELES and TEL AVIV, Israel, Feb. 09, 2026 (GLOBE NEWSWIRE) -- HUB Cyber Security Ltd. (NASDAQ:HUBC) ("HUB" or the "Company"), a global leader in secured data fabric and perpetual verification infrastructure, today announced the commercial launch of SecureRide™, its purpose-built trust infrastructure for the Transportation Network Companies (TNCs), in partnership with Fare Co-op, the driver-owned, city-managed rideshare platform. SecureRide™ debuts as part of Fare Co-op Platform 2.0, introducing always-on, real-time verification of both drivers and riders, fundamentally replacing the static, point-in-time safety checks that dominate today's rideshare industry. The TNC market generat

    2/9/26 8:02:51 AM ET
    $HUBC
    Computer Communications Equipment
    Telecommunications

    HUB Cyber Security Issues CEO Letter to Shareholders

    TEL AVIV, Israel, Feb. 04, 2026 (GLOBE NEWSWIRE) -- HUB Cyber Security Ltd. (NASDAQ:HUBC) ("HUB" or the "Company"), a global leader in confidential computing and secured data fabric technologies, today announced an open letter by its CEO, Noah Hershcoviz, to its shareholders. Dear Shareholders, HUB operates in environments where trust failure is not an option. The Company's foundation is built on military-grade cybersecurity and Secured Data Fabric ("SDF") infrastructure designed to secure, govern, and operationalize sensitive data across regulated, sovereign, and adversarial environments. That foundation continues to strengthen through HUB's deployments, ongoing institutional adoption,

    2/4/26 8:57:10 AM ET
    $HUBC
    Computer Communications Equipment
    Telecommunications

    MediaCo's EstrellaTV Extends Breakout Momentum to Start 2026, Delivering Category-Leading Prime Time Growth

    EstrellaTV, a division of MediaCo Holding Inc. (NASDAQ:MDIA), opened 2026 with decisive momentum, closing January with its fourth consecutive month of year-over-year prime time growth among Adults 18–49 and solidifying its position as the fastest-growing Spanish-language television network. So far this season, EstrellaTV has posted a +46% increase in prime time, the largest percentage gain among all major Spanish-language broadcasters. Over the same period, Telemundo delivered a +9% increase, while Univision and UniMás declined by -17% and -37%, respectively. Key Performance Highlights Prime Time Strength: EstrellaTV closed the final week of January averaging 33.2k Adults 18–49 viewe

    2/3/26 5:00:00 PM ET
    $MDIA
    Broadcasting
    Consumer Discretionary

    $ACRV
    $HUBC
    $LASE
    $MDIA
    SEC Filings

    View All

    SEC Form 424B4 filed by Laser Photonics Corporation

    424B4 - Laser Photonics Corp (0001807887) (Filer)

    2/9/26 12:19:12 PM ET
    $LASE
    Industrial Machinery/Components
    Miscellaneous

    SEC Form EFFECT filed by Laser Photonics Corporation

    EFFECT - Laser Photonics Corp (0001807887) (Filer)

    2/9/26 12:15:24 AM ET
    $LASE
    Industrial Machinery/Components
    Miscellaneous

    Laser Photonics Corporation filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Laser Photonics Corp (0001807887) (Filer)

    2/4/26 5:00:25 PM ET
    $LASE
    Industrial Machinery/Components
    Miscellaneous

    $ACRV
    $HUBC
    $LASE
    $MDIA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO Nassif Mikheal bought $486 worth of shares (49 units at $9.93) (SEC Form 4)

    4 - NEOGEN CORP (0000711377) (Issuer)

    2/2/26 4:36:07 PM ET
    $NEOG
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Amendment: Senior Vice President Ranalli Tamara A. was granted 101,626 shares (SEC Form 4)

    4/A - NEOGEN CORP (0000711377) (Issuer)

    1/29/26 10:30:09 AM ET
    $NEOG
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Senior Vice President Ranalli Tamara A. was granted 50,813 shares (SEC Form 4)

    4 - NEOGEN CORP (0000711377) (Issuer)

    1/26/26 9:34:27 AM ET
    $NEOG
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $ACRV
    $HUBC
    $LASE
    $MDIA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO Nassif Mikheal bought $486 worth of shares (49 units at $9.93) (SEC Form 4)

    4 - NEOGEN CORP (0000711377) (Issuer)

    2/2/26 4:36:07 PM ET
    $NEOG
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    President and CEO Blume-Jensen Peter bought $82,124 worth of shares (49,000 units at $1.68) (SEC Form 4)

    4 - Acrivon Therapeutics, Inc. (0001781174) (Issuer)

    1/16/26 4:02:48 PM ET
    $ACRV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Financial Officer Levy Adam D. bought $14,999 worth of shares (8,832 units at $1.70), increasing direct ownership by 73% to 20,983 units (SEC Form 4)

    4 - Acrivon Therapeutics, Inc. (0001781174) (Issuer)

    1/16/26 4:01:38 PM ET
    $ACRV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACRV
    $HUBC
    $LASE
    $MDIA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Neogen downgraded by William Blair

    William Blair downgraded Neogen from Outperform to Mkt Perform

    7/29/25 3:32:27 PM ET
    $NEOG
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Piper Sandler resumed coverage on Acrivon Therapeutics with a new price target

    Piper Sandler resumed coverage of Acrivon Therapeutics with a rating of Overweight and set a new price target of $6.00

    5/5/25 8:30:14 AM ET
    $ACRV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Maxim Group initiated coverage on Eco Wave Power Global AB with a new price target

    Maxim Group initiated coverage of Eco Wave Power Global AB with a rating of Buy and set a new price target of $15.00

    3/11/25 8:31:03 AM ET
    $WAVE
    Electric Utilities: Central
    Utilities

    $ACRV
    $HUBC
    $LASE
    $MDIA
    Leadership Updates

    Live Leadership Updates

    View All

    MediaCo Appoints Maire Mason to Lead Local Radio and Television Operations, Driving Major New York Market Shift

    Veteran Executive Joins MediaCo to Oversee NYC, Chicago, and Denver with Additional Expansion Planned MediaCo Holding Inc. (NASDAQ:MDIA) today announced the appointment of Maire Mason as Vice President and General Manager of Local MediaCo Markets, marking a significant leadership move in the New York radio and television landscape. In this role, Mason will oversee MediaCo's local radio and television operations across New York City, Chicago, and Denver, with responsibility for marquee brands including HOT 97 (WQHT-FM), WBLS-FM, Luna 107.5 (WBLS-HD2), La Buena (WQHT-HD2), and EstrellaTV's WMBC-TV in the New York tri-state area. MediaCo expects Mason's responsibilities to expand to additi

    1/26/26 8:00:00 AM ET
    $MDIA
    Broadcasting
    Consumer Discretionary

    HUB Cyber Security Appoints Limor Zur-Stoller as Chief Financial Officer

    TEL AVIV, Israel, Jan. 12, 2026 (GLOBE NEWSWIRE) -- HUB Cyber Security Ltd. (NASDAQ:HUBC) ("HUB" or the "Company"), a global provider of confidential computing, secured data fabric, and regulated AI trust infrastructure, today announced the appointment of Limor Zur‑Stoller as Chief Financial Officer, effective immediately. Ms. Zur-Stoller brings more than 20 years of senior financial leadership experience across public and private companies, including Nasdaq and TASE listed organizations, high growth technology ventures, and complex global operating environments. Her expertise spans capital markets execution, IPOs, fundraising, mergers and acquisitions, post-merger integration, and financ

    1/12/26 10:04:25 AM ET
    $HUBC
    Computer Communications Equipment
    Telecommunications

    HUB Cyber Security Strengthens Board and Provides Governance Update

    TEL AVIV, Israel, Dec. 22, 2025 (GLOBE NEWSWIRE) -- HUB Cyber Security Ltd. (NASDAQ:HUBC) ("HUB" or the "Company"), a global provider of confidential computing and secured data fabric technologies, today announced the appointment by its shareholders of Vineet Malhotra to its Board of Directors and provided a governance and capital framework update as the Company advances its long-term strategy. Board of Directors Update The Company's expanded Board of Directors reflects a governance structure aligned with HUB's focus on regulated infrastructure, financial systems, and risk-managed execution. Following the appointment of Mr. Malhotra, the Board includes independent members Renah Persofsky

    12/22/25 7:38:05 AM ET
    $HUBC
    Computer Communications Equipment
    Telecommunications

    $ACRV
    $HUBC
    $LASE
    $MDIA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Neogen Corporation

    SC 13G - NEOGEN CORP (0000711377) (Subject)

    11/14/24 4:28:12 PM ET
    $NEOG
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    SEC Form SC 13G filed by Vincerx Pharma Inc.

    SC 13G - Vincerx Pharma, Inc. (0001796129) (Subject)

    11/14/24 3:39:40 PM ET
    $VINC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Vincerx Pharma Inc.

    SC 13G/A - Vincerx Pharma, Inc. (0001796129) (Subject)

    11/14/24 11:57:03 AM ET
    $VINC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACRV
    $HUBC
    $LASE
    $MDIA
    Financials

    Live finance-specific insights

    View All

    Acrivon Therapeutics Announces Positive ACR-368 Phase 2b Endometrial Cancer Clinical Data with EU Expansion to Accelerate Enrollment, Initial ACR-2316 Clinical Data, and ACR-6840, its Next AP3-Enabled Development Candidate, Targeting CDK11

    Electronic data capture (EDC) extract from the ongoing ACR-368 registrational-intent Phase 2b monotherapy trial in OncoSignature-positive (BM+) subjects with endometrial cancer (EC) showed 39% overall response rate (ORR) and 44% in subjects with ≤2 prior lines of therapy* Analysis of data from all-comer subjects with serous subtype and ≤2 prior lines of therapy, a high unmet need population, showed a confirmed ORR (cORR) of 52%, and within BM+ subjects cORR was 67%, consistent with higher BM levels across serous subjects Arm 3 is enrolling up to 90 subjects with serous subtype and ≤2 prior lines of therapy, without requirement for a tumor biopsy, for treatment with ACR-368 plus ultra-low d

    1/8/26 7:30:00 AM ET
    $ACRV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Neogen Announces Second-Quarter 2026 Results

    Revenue of $224.7 million, a decrease of 2.8% YoY; Core growth1 increased 2.9% YoY Net loss of $15.9 million; Adjusted Net Income1 of $22.6 million Adjusted EBITDA1 of $48.7 million; Adjusted EBITDA margin1 increased 470 bps sequentially Company hires key senior commercial leaders Petrifilm manufacturing transition remains on track Raising FY 2026 revenue and Adjusted EBITDA guidance 1 Non-GAAP financial measures; see explanations and reconciliations that follow Neogen Corporation (NASDAQ:NEOG) announced today the results of the second quarter ended November 30, 2025. "I am exceptionally proud of the Neogen team as we have initiated the first phase of our strategic tr

    1/8/26 7:00:00 AM ET
    $NEOG
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Acrivon Therapeutics to Announce Clinical Update on its Ongoing Phase 2b Studies and Planned Confirmatory Phase 3 Trial for ACR-368, Initial Clinical Data on ACR-2316, and Other AP3 Pipeline Updates via Webcast

    WATERTOWN, Mass., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. ("Acrivon" or "Acrivon Therapeutics") (NASDAQ:ACRV), a clinical stage biotechnology company discovering and developing precision medicines utilizing its proprietary Generative Phosphoproteomics AP3 (Acrivon Predictive Precision Proteomics) platform designed to interpret and quantify global compound-specific, drug-regulated effects in the intact cell which is deployed for rational drug design and predictive clinical development, today announced it will be providing ACR-368 and ACR-2316 clinical data and other updates via a press release at 7:30 a.m. ET, and conference call and webcast at 8:30 a.m. ET, both on Thu

    1/6/26 7:30:00 AM ET
    $ACRV
    Biotechnology: Pharmaceutical Preparations
    Health Care